Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-062355

Director sold 100,000 shares at $0.24 ($24,100)

  • Director acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2014-10-20 Option exercise +100,000 $0.04 $3,500 1,493,631 D: show line 1 in the form
Kraus Al Director 2014-10-20 Sale −100,000 $0.24 $24,100 1,393,631 D: show line 2 in the form
Open-market sales · 100,000 sh · avg $0.24 · $24,100

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kraus Al Director 2014-10-20 Option exercise · Stock Option −100,000 5,919,328 D: show line 3 in the form
Loading xslF345X03/v391797_4.xml…